| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Laboratory Studies for Diagnosing and Managing Inflammatory Bowel Disease | 2025-12-08 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Transcatheter Arterial Chemoembolization | 2025-12-08 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Sacral Nerve Neuromodulation | 2025-12-08 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Vocal Cord Paralysis/Insufficiency Treatments | 2025-12-08 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Transcatheter Pulmonary Valve Implantation | 2025-12-08 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Atidarsagene autotemcel (Lenmeldy) | 2025-12-08 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Axatilimab-csfr (Niktimvo) | 2025-12-08 |
| BCBS Highmark Penn Medicare Advantage | Omalizumab (Xolair) and Omalizumab Biosimilars | 2025-12-08 |
| BCBS Highmark Penn Medicare Advantage | Zolbetuximab-clzb (Vyloy) | 2025-12-08 |
| BCBS Highmark NY and West NY | Manipulation Services | 2025-12-08 |